The PE Ratio as of November 2024 (TTM) for Adial Pharmaceuticals, Inc. (ADIL) is -0.25

According to Adial Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.25. This represents a change of -37.42% compared to the average of -0.40 of the last 4 quarters.

Adial Pharmaceuticals, Inc. (ADIL) Historical PE Ratio (quarterly & annually)

How has ADIL PE Ratio performed in the past?

The mean historical PE Ratio of Adial Pharmaceuticals, Inc. over the last ten years is -11.00. The current -0.25 PE Ratio has changed 127.32% with respect to the historical average. Over the past ten years (40 quarters), ADIL's PE Ratio was at its highest in in the June 2023 quarter at 1.37. The PE Ratio was at its lowest in in the March 2016 quarter at -145.50.

Adial Pharmaceuticals, Inc. (ADIL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Adial Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adial Pharmaceuticals, Inc. (ADIL) Average PE Ratio

How has ADIL PE Ratio performed in the past?

The current PE Ratio of Adial Pharmaceuticals, Inc. (ADIL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Adial Pharmaceuticals, Inc. (ADIL) PE Ratio vs. Peers

How is ADIL’s PE Ratio compared to its peers?

Adial Pharmaceuticals, Inc.’s PE Ratio is less than TransCode Therapeutics, Inc. (-0.20), less than Aditxt, Inc. (-0.02), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.05), less than Avenue Therapeutics, Inc. (-0.24), less than Applied Molecular Transport Inc. (-0.14), greater than Catalyst Biosciences, Inc. (-0.44), greater than Aileron Therapeutics, Inc. (-3.16), less than Bio-Path Holdings, Inc. (-0.14), greater than Benitec Biopharma Inc. (-2.02), greater than Hoth Therapeutics, Inc. (-0.82), less than Revelation Biosciences, Inc. (-0.09), greater than NeuroBo Pharmaceuticals, Inc. (-0.53), greater than Virax Biolabs Group Limited (-0.68), greater than RenovoRx, Inc. (-3.08), greater than Axcella Health Inc. (-10.73), less than Better Therapeutics, Inc. (-0.00), less than Pasithea Therapeutics Corp. (-0.23), greater than Onconova Therapeutics, Inc. (-1.15), less than Diffusion Pharmaceuticals Inc. (-0.00), less than Aeterna Zentaris Inc. (-0.10), less than Tonix Pharmaceuticals Holding Corp. (-0.00),

Build a custom stock screener for Adial Pharmaceuticals, Inc. (ADIL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adial Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adial Pharmaceuticals, Inc. (ADIL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adial Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.